Trial Profile
A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry Eye
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Sep 2014
Price :
$35
*
At a glance
- Drugs Cilomilast (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Alcon
- 09 Jun 2014 New trial record